{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:07Z","timestamp":1772165887939,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe asthma is a complex heterogeneous disease typically requiring advanced therapies. Underlying the treatment of all asthma, however, is the consistent recommendation across international guidelines to ensure that adherence to therapy is adequate. Currently, there is no consensus on an objective marker of adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a prospective observational study of 17 participants taking oral prednisolone using serum prednisolone levels as a marker of adherence, and sputum eosinophilia as a marker of control of type 2 airway inflammation. Based on these biomarkers, we classified participants into a non-adherent and an adherent cohort, and further stratified by the presence of ongoing sputum eosinophilia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 3 non-adherent participants and 14 who were adherent, based on their serum prednisolone levels. Stratification using sputum eosinophil counts identified one participant as having ongoing sputum eosinophilia in the setting of non-adherence, while six were identified as steroid resistant with ongoing sputum eosinophilia despite adherence to oral prednisolone therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum prednisolone can be used an objective marker of adherence in those patients with severe asthma taking daily oral prednisolone. In combination with sputum eosinophil counts, a steroid resistant cohort can be distinguished from one with ongoing inflammation in the setting of non-adherence. This information can then be used by clinicians to differentiate the optimal next steps for treatment in these specific populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Participants were recruited as part of the Markers of Inflammation in the Management of Severe Asthma (MIMOSA) study, trial registration\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=371153&amp;isReview=true\">ACTRN12616001015437<\/jats:ext-link>\n                      , 02 August 2016.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-020-01263-y","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T10:02:47Z","timestamp":1598522567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-9374","authenticated-orcid":false,"given":"J. Michael","family":"Ramsahai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Niven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gael","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A. B.","family":"Wark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"issue":"7","key":"1263_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.rmed.2006.03.031","volume":"100","author":"SP Peters","year":"2006","unstructured":"Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med. 2006;100(7):1139\u201351.","journal-title":"Respir Med"},{"issue":"2","key":"1263_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u201373.","journal-title":"Eur Respir J"},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2466-9-24","volume":"9","author":"K Bahadori","year":"2009","unstructured":"Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, et al. Economic burden of asthma: a systematic review. BMC pulmonary medicine. 2009;9:24.","journal-title":"BMC pulmonary medicine."},{"key":"1263_CR4","volume-title":"2018 GINA report, global strategy for asthma management and prevention","author":"Asthma GIf","year":"2018","unstructured":"Asthma GIf. 2018 GINA report, global strategy for asthma management and prevention. https:\/\/ginasthma.org\/2018-gina-report-global-strategy-for-asthma-management-and-prevention\/; 2018."},{"issue":"4","key":"1263_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","volume":"199","author":"LG Heaney","year":"2019","unstructured":"Heaney LG, Busby J, Bradding P, Chaudhuri R, Mansur AH, Niven R, et al. Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma. Am J Respir Crit Care Med. 2019;199(4):454\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"1263_CR6","volume-title":"Adherence to long-term therapies: evidence for action","author":"E Sabate","year":"2003","unstructured":"Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003."},{"issue":"4","key":"1263_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","volume":"14","author":"EF Juniper","year":"1999","unstructured":"Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902\u20137.","journal-title":"Eur Respir J"},{"issue":"5","key":"1263_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","volume":"99","author":"EF Juniper","year":"2005","unstructured":"Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553\u20138.","journal-title":"Respir Med"},{"issue":"4","key":"1263_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","volume":"100","author":"EF Juniper","year":"2006","unstructured":"Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying \u2018well-controlled\u2019 and \u2018not well-controlled\u2019 asthma using the asthma control questionnaire. Respir Med. 2006;100(4):616\u201321.","journal-title":"Respir Med"},{"issue":"2","key":"1263_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"1","key":"1263_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1164\/ajrccm.158.1.9705031","volume":"158","author":"PG Gibson","year":"1998","unstructured":"Gibson PG, Wlodarczyk JW, Hensley MJ, Gleeson M, Henry RL, Cripps AW, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med. 1998;158(1):36\u201341.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Pt 2","key":"1263_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1258\/0004563053492810","volume":"42","author":"LJ Owen","year":"2005","unstructured":"Owen LJ, Gillingwater S, Keevil BG. Prednisolone measurement in human serum using liquid chromatography tandem mass spectrometry. Ann Clin Biochem. 2005;42(Pt 2):105\u201311.","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"1263_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.200902-0166OC","volume":"180","author":"J Gamble","year":"2009","unstructured":"Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2009;180(9):817\u201322.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9347","key":"1263_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","volume":"360","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (London, England). 2002;360(9347):1715\u201321.","journal-title":"Lancet (London, England)"},{"issue":"3","key":"1263_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1183\/09031936.06.00137704","volume":"27","author":"L Jayaram","year":"2006","unstructured":"Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J. 2006;27(3):483\u201394.","journal-title":"Eur Respir J"},{"issue":"32","key":"1263_CR16","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.2174\/1871524915666150710123415","volume":"21","author":"M Malerba","year":"2015","unstructured":"Malerba M, Radaeli A, Olivini A, Ragnoli B, Ricciardolo F, Montuschi P. The combined impact of exhaled nitric oxide and sputum Eosinophils monitoring in asthma treatment: a prospective cohort study. Curr Pharm Des. 2015;21(32):4752\u201362.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"1263_CR17","first-page":"334","volume":"30","author":"WL Cao","year":"2007","unstructured":"Cao WL, Sun YC, Yao WZ. A study on a therapeutic protocol to improve the control of persistent asthma by monitoring sputum eosinophil counts. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30(5):334\u20138.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"1","key":"1263_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1067\/mai.2003.97","volume":"111","author":"DY Leung","year":"2003","unstructured":"Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003;111(1):3\u201322 quiz 3.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1263_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/09546634.2010.487887","volume":"23","author":"MA El-Darouti","year":"2012","unstructured":"El-Darouti MA, Mashaly HM, El-Nabarawy E, El-Tawdy AM, Fawzy MM, Salem DS, et al. Comparative study of the effect of a daily steroid regimen versus a weekly oral pulse steroid regimen on morphological changes, blood sugar, bone mineral density and suprarenal gland activity. J Dermatolog Treat. 2012;23(1):4\u201310.","journal-title":"J Dermatolog Treat"},{"key":"1263_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2466-8-1","volume":"8","author":"P Schuetz","year":"2008","unstructured":"Schuetz P, Christ-Crain M, Schild U, Suess E, Facompre M, Baty F, et al. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulmonary Med. 2008;8:1.","journal-title":"BMC Pulmonary Med"},{"issue":"2","key":"1263_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1183\/13993003.01359-2015","volume":"47","author":"A Agusti","year":"2016","unstructured":"Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410\u20139.","journal-title":"Eur Respir J"},{"issue":"2","key":"1263_CR22","first-page":"S18","volume":"209","author":"JM Ramsahai","year":"2018","unstructured":"Ramsahai JM, Wark PA. Appropriate use of oral corticosteroids for severe asthma. Med J Aust. 2018;209(2):S18\u2013s21.","journal-title":"Med J Aust"},{"issue":"25","key":"1263_CR23","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","volume":"376","author":"P Nair","year":"2017","unstructured":"Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, et al. Oral glucocorticoid-sparing effect of Benralizumab in severe asthma. N Engl J Med. 2017;376(25):2448\u201358.","journal-title":"N Engl J Med"},{"issue":"26","key":"1263_CR24","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, et al. Efficacy and safety of Dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378(26):2475\u201385.","journal-title":"N Engl J Med"},{"issue":"13","key":"1263_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","volume":"371","author":"EH Bel","year":"2014","unstructured":"Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371(13):1189\u201397.","journal-title":"N Engl J Med"},{"issue":"2","key":"1263_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaip.2019.09.020","volume":"8","author":"V Plaza","year":"2020","unstructured":"Plaza V, Giner J, Curto E, Alonso-Ortiz MB, Orue MI, Vega JM, et al. Determinants and differences in satisfaction with the inhaler among patients with asthma or COPD. J Allergy Clin Immunol Pract. 2020;8(2):645\u201353.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"1263_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003088-197904020-00004","volume":"4","author":"ME Pickup","year":"1979","unstructured":"Pickup ME. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet. 1979;4(2):111\u201328.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"1263_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/thorax.56.5.345","volume":"56","author":"DN Payne","year":"2001","unstructured":"Payne DN, Wilson NM, James A, Hablas H, Agrafioti C, Bush A. Evidence for different subgroups of difficult asthma in children. Thorax. 2001;56(5):345\u201350.","journal-title":"Thorax."},{"issue":"8","key":"1263_CR29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/BF02730664","volume":"71","author":"SK Kabra","year":"2004","unstructured":"Kabra SK, Lodha R. Management of unresponsive asthma. Indian J Pediatr. 2004;71(8):729\u201332.","journal-title":"Indian J Pediatr"},{"issue":"4","key":"1263_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/thoraxjnl-2015-208242","volume":"71","author":"XN Choo","year":"2016","unstructured":"Choo XN, Pavord ID. Morbidity associated with oral corticosteroids in patients with severe asthma. Thorax. 2016;71(4):302\u20134.","journal-title":"Thorax."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01263-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T19:19:31Z","timestamp":1630005571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01263-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01263-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-22760\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"20 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Hunter New England Human Research Ethics (16\/05\/18\/3.03) and University of Newcastle Human Research Ethics Committees (H-2016-0261). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}